Literature DB >> 35919541

Do Proton-Pump Inhibitors Cause CKD and Progression of CKD?: CON.

Liza Cholin1, Georges Nakhoul1.   

Abstract

Entities:  

Keywords:  chronic kidney disease; nephropharmacology; proton-pump inhibitors

Mesh：

Substances：

Year:  2022        PMID： 35919541      PMCID： PMC9337885          DOI： 10.34067/KID.0005852021

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  12 in total

1.  Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.

Authors:  Jiachuan Xiong; Ting He; Min Wang; Ling Nie; Ying Zhang; Yiqin Wang; Yunjian Huang; Bing Feng; Jingbo Zhang; Jinghong Zhao
Journal:  J Nephrol       Date:  2019-03-19       Impact factor: 3.902

2.  Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.

Authors:  Benjamin Lazarus; Yuan Chen; Francis P Wilson; Yingying Sang; Alex R Chang; Josef Coresh; Morgan E Grams
Journal:  JAMA Intern Med       Date:  2016-02       Impact factor: 21.873

3.  Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.

Authors:  Yan Xie; Benjamin Bowe; Tingting Li; Hong Xian; Sumitra Balasubramanian; Ziyad Al-Aly
Journal:  J Am Soc Nephrol       Date:  2016-04-14       Impact factor: 10.121

4.  Biopsy-proven acute interstitial nephritis, 1993-2011: a case series.

Authors:  Angela K Muriithi; Nelson Leung; Anthony M Valeri; Lynn D Cornell; Sanjeev Sethi; Mary E Fidler; Samih H Nasr
Journal:  Am J Kidney Dis       Date:  2014-06-11       Impact factor: 8.860

5.  Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.

Authors:  Derk C F Klatte; Alessandro Gasparini; Hong Xu; Pietro de Deco; Marco Trevisan; Anna L V Johansson; Björn Wettermark; Johan Ärnlöv; Cynthia J Janmaat; Bengt Lindholm; Friedo W Dekker; Josef Coresh; Morgan E Grams; Juan J Carrero
Journal:  Gastroenterology       Date:  2017-06-02       Impact factor: 22.682

6.  Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis.

Authors:  C H Grant; K A Gillis; J S Lees; J P Traynor; P B Mark; K I Stevens
Journal:  QJM       Date:  2019-11-01

7.  Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study.

Authors:  Yen-Chun Peng; Cheng-Li Lin; Hong-Zen Yeh; Chi-Sen Chang; Yu-Lin Wu; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

8.  Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.

Authors:  Pradeep Arora; Anu Gupta; Mojgan Golzy; Nilang Patel; Randolph L Carter; Kabir Jalal; James W Lohr
Journal:  BMC Nephrol       Date:  2016-08-03       Impact factor: 2.388

9.  Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression.

Authors:  Liza Cholin; Tarek Ashour; Ali Mehdi; Jonathan J Taliercio; Remy Daou; Susana Arrigain; Jesse D Schold; George Thomas; Joseph Nally; Nazih L Nakhoul; Georges N Nakhoul
Journal:  BMC Nephrol       Date:  2021-07-15       Impact factor: 2.585

10.  Molecular pathways driving omeprazole nephrotoxicity.

Authors:  Miguel Fontecha-Barriuso; Diego Martín-Sanchez; Julio M Martinez-Moreno; Daniela Cardenas-Villacres; Susana Carrasco; Maria D Sanchez-Niño; Marta Ruiz-Ortega; Alberto Ortiz; Ana B Sanz
Journal:  Redox Biol       Date:  2020-02-12       Impact factor: 11.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.